Skip to main content
Vinod Rustgi, MD, Gastroenterology, New Brunswick, NJ, Robert Wood Johnson University Hospital


Gastroenterology New Brunswick, NJ

Biliary Tract Disease, Hepatology & Liver Transplantation, Clinical Informatics

Distinguished Professor of Medicine (Gastroenterology)/Director of Hepatology. Professor of Epidemiology Professor of Pathology & Lab Medicine Rutgers Robert Wood Johnson Medical School

Dr. Rustgi is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Rustgi's full profile

Already have an account?

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityM.B.A, 2005 - 2009
  • Clinical Center at the National Institutes of Health
    Clinical Center at the National Institutes of Health1987
  • Stanford Health Care
    Stanford Health Care1985
  • Inova Fairfax Medical CampusChief Residency, Internal Medicine, 1983 - 1984
  • Stanford Health Care
    Stanford Health CareFellowship, Gastroenterology, 1982 - 1983
  • MedStar HealthResidency, Internal Medicine, 1982
  • Baylor College of Medicine
    Baylor College of MedicineInternship, Internal Medicine, 1979 - 1980
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineClass of 1979
  • Yale University
    Yale UniversityB.A, 1971 - 1975

Certifications & Licensure

  • NJ State Medical License
    NJ State Medical License 2016 - 2023
  • MD State Medical License
    MD State Medical License 2002 - 2017
  • DC State Medical License
    DC State Medical License 1998 - 2008
  • NY State Medical License
    NY State Medical License 1986 - Present
  • PA State Medical License
    PA State Medical License 1983 - 2016
  • CA State Medical License
    CA State Medical License 1982 - Present
  • VA State Medical License
    VA State Medical License 1981 - 2022
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Gastroenterology

Awards, Honors, & Recognition

  • Medical Consultant. Liver Diseases Section, National Institutes of Health, 1993-1994, 1994
  • President William Earl Clark Society, 1991-1992, 1992
  • Fellow American College of Physicians, 1989
  • Join now to see all

Clinical Trials

Publications & Presentations


Journal Articles

  • The disposition of 6-deoxyayclovir, a xanthine oxidase activated prodrug of acyclovir, in the isolated perfused rat liver.  
    Jones DB, Rustgi VK, Kornhauser DM, Hoofnagle JH, Jones EA, Hepatology (2): 345-348
  • Influence of lymphokines on bile flow in the rat.  
    Rustgi VK, Jones DB, Dinarello CA, Hoofnagle JH, Liver 7: 149-154
  • Hepatitis C virus treatment related anemia is associated with higher sustained virologic response rate.  
    Sulkowski MS, Shiffman ML…Rustgi V…et al, Gastroenterology;139 (5): 1602-11, 1611.e1
  • Join now to see all

Books/Book Chapters

  • Join now to see all


  • A Phase II Dose-ranging, Placebo-controlled Trial of Adefovir Dipivoxil for the Treatment of Chronic Hepatitis B Virus Infection.
    Jeffers L, Heathcote J, Wright T, … Rustgi V, … Jaffe HS, International Conference on Antiviral Research
  • Lamivudine Treatment for One Year in Previously Untreated U.S. Hepatitis B Patients: Histologic Improvement and Hepatitis B e-antigen (HBeAg) Seroconversion.
    Dienstag J, Schiff E, Wright T, …Rustgi V, DDW, New Orleans
  • A Randomized, Double-blind Study of Neoral vs. Sandimmune in Primary Liver Transplant Recipients with Two Year Follow-up.
    Donovan J, …Rustgi VK, ASTP Meeting, Chicago IL
  • Join now to see all


  • A phase 2 dose-escalation study of albuferon combined with ribavirin in non-responders to prior interferon based therapy for chronic hepatitis C infection. 
    Reddy KR, Rustgi VK, Zeuzem S, Gane E, Lim SG, Jia JD, Belanger B, George S, Harb G, annual European Association for the Study of the Liver Meeting
  • Valopicitabine (NM283), alone or with peg-interferon, compared to peg Interferon/Ribavirin (PEGIFN/RBV) retreatment in hepatitis C patients with prior non-response to ... 
    Afdhal N, O’Brien C, Godofsky E, Rodriguez-Torres M, Pappas SC, Pockros P… Rustgi VK… et al, annual European Association for the Study of the Liver Meeting
  • Pre-dosing taribavirin prior to combination therapy with pegylated interferon alfa-2B versus standard combination dosing: 24-week interim results examining safety and ... 
    Palmer M, Rubin R, Rustgi VK, Li D & Murphy B, annual European Association for the Study of the Liver Meeting
  • Join now to see all

Professional Memberships

Other Languages

  • Hindi

Hospital Affiliations